Johnson & Johnson Details Launch Plans Regarding Kenvue IPO Roadshow
Pharmaceutical powerhouse J&J expects to cost its Kenvue IPO shares at $20 to $23 for a possible $40 billion firm valuation. Johnson & Johnson (NYSE: JNJ) plans to cost shares of….
Latest Posts
- JPMorgan Says Bitcoin is Undervalued Relative to Gold, Sets Target of $126k
- XRP Price To Rally 5,600% To $200? Crypto Analyst Lays Out The Possibilities
- PYTH skyrockets 60% as US government taps Pyth Network to verify economic data on-chain
- JPMorgan says Bitcoin is undervalued compared to gold as volatility plummets
- TRON Stablecoin Network Grows: TRC-20 USDT Flows From Exchanges Hit Record Highs
- Toncoin Gets Listed on Robinhood; TON Price Rises 5%